Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04408677
Other study ID # ZCI01
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date June 2, 2021
Est. completion date September 22, 2021

Study information

Verified date February 2023
Source Zilia Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Mainstream oximetry devices use two-wavelength systems to photograph the retina and estimate the oxygen saturation levels in the retinal vessels by comparing light absorption in the blood of the vessels at the selected wavelengths. This method limits the measurements to large retinal vessels, depends heavily on calibration and is non-reproducible across machines. The few numbers of wavelengths used (two) also makes it very susceptible to noise (such as cataract). These shortcomings have largely limited the use of retinal oximetry in clinical practice. A new technology for retinal oximetry has recently been developed to address issues of dual-wavelength oximeters. Zilia Ocular's oximetry machine uses multi-wavelengths of light to take continuous oxygenation measurements of any targeted regions of the retina. It can measure any area of the retina, including the blood vessels, retinal tissues and the optic nerve head. Its multi-wavelength design also allows it to be less susceptible to noise, more precise and reproducible. This technology has the potential to extend our understanding of retinal pathologies, serve as a new marker for retinal health and even be used as a diagnostic tool to detect retinal injuries before they become visible. Zilia's novel technology is one of its kind, allowing continuous and accurate measurements of the retina's oxygen saturation. In order to apply this technology to study and investigate retinal diseases, we need to first examine its performance in normal eyes and build a normative database as a reference. Thus, the purpose of the current study is to build a database of baseline oximetry values in healthy Caucasian subjects. The reproducibility of the measurements will also be studied in a subset of patients.


Description:

STUDY OBJECTIVES Objectives Primary: 1. To measure the oxygen saturation at different locations on the retina (macula, optic nerve head, nasal retina) in order to provide the range of these values in normal eyes. Secondary: 1. To assess the repeatability of the device's measurements (on a subset of patients). 2. To assess the variability of measurements between the two eyes (on a subset of patients). Outcomes Primary Outcome: 1. Normative values of the retinal oxygen saturation at different locations on the retina. Secondary Outcomes: 1. Intraclass correlation coefficient of the measurements on the same patient at the same visit. 2. Percent difference between the measurements of the two eyes. STUDY HYPOTHESES Primary: 1. Oxygen saturation should have a consistent range among healthy subjects. Secondary: 1. Intraclass classification (ICC) between two measurements on the same eye of the same participant should be at least 90%. 2. Measurements between the two eyes should have a percent difference less than 5%. STUDY DESIGN Type of study: single-center. Expected number of subjects: For primary objective: N=120 subjects For secondary objective #1: n= 62 For secondary objective #2: n= 12


Recruitment information / eligibility

Status Terminated
Enrollment 33
Est. completion date September 22, 2021
Est. primary completion date September 22, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients above 18 years old, able to consent and willing to undergo mydriasis. - Caucasian descent. - Intraocular pressure = 21 mmHg. - Normal ophthalmological exam. Exclusion Criteria: - Any history of systemic disease, which could affect the eye or oxygen levels (eg: diabetes, severe cardiovascular or respiratory disease). - History of epilepsy. - Prior intraocular surgery (except cataract surgery). - Any history or signs of retinal or optic nerve diseases. - Pregnancy, or breastfeeding. - Familial history of glaucoma. - Ametropia > 6 Diopters. - Pupil dilation < 3.6 mm. - Current smoker.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Zilia Ocular
Measurement of the oxygen saturation in the eye fundus

Locations

Country Name City State
Canada Hôpital du Saint-Sacrement Québec

Sponsors (2)

Lead Sponsor Collaborator
Zilia Inc. CHU de Quebec-Universite Laval

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Normative values of the retinal oxygen saturation at different locations on the retina Oxygen saturation measurement in the eye fundus of healthy subjects from different age groups 12-15 months
Secondary Intraclass correlation coefficient of the measurements on the same patient at the same visit Repeatability of the eye fundus oxygen saturation measurements (same subject, same visit, same eye, same eye fundus location) 12-15 months
Secondary Percent difference between the measurements of the two eyes. Variability of the eye fundus oxygen saturation measurements between the right and left eyes (same subject, same visit, different eye, same eye fundus location) 12-15 months
See also
  Status Clinical Trial Phase
Completed NCT00431691 - Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans. Phase 4
Completed NCT01157338 - Clinical Significance of Retinal Emboli During Diagnostic and Therapeutic Cardiac Catheterization N/A
Completed NCT03326908 - Description of the Interdigitation Retinal Area by SD-OCT: An Exploratory Study N/A
Completed NCT04794634 - Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers N/A
Recruiting NCT05747742 - Effect of Different Intensities of Repeated Low-Level Red-Light Therapy on Choroidal and Retinal Blood Flow Among Adults N/A
Completed NCT00709423 - Effects of Moxaverine and Placebo on Ocular Blood Flow Phase 2
Completed NCT00814008 - The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp Phase 2
Completed NCT00451763 - Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia Phase 3
Completed NCT00706927 - Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension N/A
Recruiting NCT02614625 - Spectral-domain Optical Coherence Tomography of the Eye N/A
Completed NCT00431730 - Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers? N/A
Completed NCT03197493 - Extension, Carbidopa-levodopa in Neovascular AMD Phase 2
Not yet recruiting NCT05796856 - Effect of Different Wavelengths of Repeated Low-Level Light Therapy on Choroidal and Retinal Blood Flow Among Adults N/A
Completed NCT00431548 - Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV) N/A